Frequency of deranged blood lipids in male patients with androgenetic alopecia
DOI:
https://doi.org/10.66344/jpad.v28i4.1188Keywords:
Androgenetic alopecia, high-density lipoproteins, low-density lipoproteins, triglyceridesAbstract
Objective To determine the frequency of deranged serum lipids in male patients with androgenetic alopecia.
Methods Cross-sectional study was conducted in the outpatients department of Dermatology, Fauji Foundation Hospital Rawalpindi over a period of six months i.e. January 2015 to June 2015. Male patients between 25-65 years with androgenetic alopecia were enrolled in the study. Blood samples for fasting serum lipids were taken during the same visit. All data were entered and analyzed.
Results Total 150 patients were included in the study according to the inclusion criteria. Mean age in high and low triglycerides patients was 46.87+10.58 years and 42.32+11.29 years, respectively. Similarly, mean age (years) in normal and low HDL was 42.17+10.87 years and 48.13+10.21 years, respectively. There were 131 (87.3%) patients who presented with high triglycerides levels whereas 19 (12.7%) patients had normal triglycerides. Similarly, there were 46 (30.7) patients who presented with normal HDL levels where as 104 (69.3) patients had low HDL levels.
Conclusion The study concluded that serum lipids were deranged in male patients of androgenetic alopecia.
References
1. Fatemi F, Rahmaniyan N, Vatankhah M, Hashemi F. Prevalence of androgenetic alopecia in women of 20-70 years in Isfahan during 2008-2009. J Pak Assoc Dermatol. 2010;20:75-8.
2. Sharquie KE, Noaimi AA, Salman HA, Hindy NA. Female pattern alopecia and lipoproteins. IPMJ. 2009;8:120-3.
3. Farajzadeh S, Esfandiarpour I, Abbasi MMH, Moghaddam SD, Hossininasab F. Evaluation of Lipid profile in women with female pattern alopecia. Iran J Dermatol. 2010;13:78-81.
4. Kapadia N, Ahmed TJ, Borhany T. Male androgenetic alopecia treated with finasteride. J Pak Assoc Dermatol. 2008;18:232-4.
5. Stough D, Stenn K, Haber R, Parsley WM, Vogel JE, Whiting DA et al. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc. 2005;80:1316-22
6. Arias-Santiago S, Arrabal-Polo MA, Buendía-Eisman A, Arrabal-Martín M, Gutiérrez-Salmerón MT, Girón-Prieto MS et al. Androgenetic alopecia as an early marker of benign prostatic hyperplasia. J Am Acad Dermatol. 2012;66:401-8.
7. Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol. 2007;17:220-2.
8. Arias-Santiago S, Gutierrez-Salmeron MT, Castellote-Caballero L, Buendia-Eisman A, Naranjo-Sintes R. Androgenetic alopecia and cardiovascular risk factors in men and women. J Am Acad Dermatol. 2010;63:420-9.
9. Arias-Santiago S, Gutierrez-Salmeron MT, Buendia-Eisman A, Giron-Prieto MS, Naranjo-Sintes R. A comparative study of dyslipidemia in men and women with androgenetic alopecia. Acta Derm Venereol. 2010;90:485-7.
10. Sadighha A, Zahed GM. Evaluation of lipid levels in androgenetic alopecia in comparison with control group. J Eur Acad Dermatol Venereol. 2009;23:80-1.
11. Nabai L, Kavand S, Robati RM, Sarraffirad N, Shagholi L, Meshkat-Razavi G. Androgenetic alopecia and insulin resistance: are they really related? Clin Exp Dermatol. 2009;34:694-7.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Bilquees, Nighat Akbar, Kiran Fatima
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
